EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Remission and response rates in obsessive–compulsive disorder: Naturalistic study

Daniel Minkin Levy, Oded Ben Arush, Sasson Zemach, Alzbeta Juven Wetzler, Joseph Zohar

Comprehensive Psychiatry · 2026

DOI: 10.1016/j.comppsych.2026.152740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2026. Verfasst von Daniel Minkin Levy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chaim Sheba Medical Center, Ramat-Gan, Israel. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Selective Serotonin Reuptake Inhibitors, Implosive Therapy, Family Therapy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite established treatments for obsessive-compulsive disorder (OCD), many patients remain symptomatic under standard care. OBJECTIVE: To evaluate long-term remission and response rates in OCD patients treated with a multimodal approach combining intensive exposure and response prevention (ERP), off-label high-dose serotonin reuptake inhibitors (OLHD-SRIs), and family-focused intervention within a "virtual hospitalization" framework. METHODS: A retrospective naturalistic study was conducted on 105 adult outpatients (mean age 27.2) treated between 2013 and 2022. Treatment included thrice-weekly ERP sessions, digital adherence monitoring, and SRI doses exceeding regulatory limits. Outcomes were measured using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and compared to a benchmark meta-analysis of 1265 patients receiving standard care. RESULTS: The mean Y-BOCS score decreased by 65.8%. A treatment response (≥35% reduction) was achieved by 86.7% of patients. Using a strict definition of remission (Y-BOCS ≤12), 67.6% of the cohort reached recovery. When compared to the benchmark study (Y-BOCS

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obsessive-Compulsive DisorderSelective Serotonin Reuptake InhibitorsImplosive TherapyFamily TherapyHumansFemaleMaleAdultRetrospective StudiesRemission InductionTreatment OutcomeYoung AdultCombined Modality TherapyMiddle Aged

Stichwörter der Autor:innen

High-dose serotonin reuptake inhibitorsObsessive compulsive disorderRemissionResponseVirtual hospitalization

Substanzen

Selective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Chaim Sheba Medical Center, Ramat-Gan, Israel.
  • Israeli Center for the Treatment of Obsessive-Compulsive and Related Disorders, Modiin, Israel.
  • The Jerusalem Mental Health Center, Jerusalem, Israel.
  • Chaim Sheba Medical Center, Post Trauma Center, Ramat-Gan, Israel; Tel Aviv University, Tel Aviv, Israel. Electronic address: jozohar@gmail.com.

Zitieren

APA

Levy, D. M., Arush, O. B., Zemach, S., Wetzler, A. J., & Zohar, J. (2026). Remission and response rates in obsessive–compulsive disorder: Naturalistic study. Comprehensive Psychiatry. https://doi.org/10.1016/j.comppsych.2026.152740

Vancouver

Levy DM, Arush OB, Zemach S, Wetzler AJ, Zohar J. Remission and response rates in obsessive–compulsive disorder: Naturalistic study. Comprehensive Psychiatry. 2026. doi:10.1016/j.comppsych.2026.152740

BibTeX
@article{Levy2026,
  author = {Levy, Daniel Minkin and Arush, Oded Ben and Zemach, Sasson and Wetzler, Alzbeta Juven and Zohar, Joseph},
  title = {Remission and response rates in obsessive–compulsive disorder: Naturalistic study},
  journal = {Comprehensive Psychiatry},
  year = {2026},
  doi = {10.1016/j.comppsych.2026.152740}
}
Kostenlos starten →